Introduction
Recurrent events together with longitudinal measurements are frequently encountered in follow-up studies. In biomedical applications, two types of longitudinal measurements are commonly observed: (i) repeated measurements collected at sampling times, and (ii) marker measurements observed when recurrent events occur. In case (i), longitudinal measurements are assumed to be a stochastic process which exists continuously over time, such as CD4 cell counts in HIV studies or other disease-related biomarkers, where recurrent events are sampling times. In case (ii), typical examples are studies with repeated marker measurements observed upon the occurrence of recurrent events, where both recurrent events and marker measurements are of scientific interests; an example is the medical charge upon the occurrence of hospitalization. For either case, the observation of longitudinal measurements and recurrent events could be terminated by censoring or a primary failure event such as death. Despite the difference in the data generating mechanisms, these two kinds of data share the same notations. This article presents a semiparametric joint model framework for both types of longitudinal measurements, (i) and (ii), with covariates information.
In the absence of informative sampling times, many authors (Wulfsohn and Tsiatis, 1997; Henderson et al., 2000; Xu and Zeger, 2001; Song, Davidian, and Tsiatis, 2002; Vonesh, Greene, and Schluchter, 2006; Song and Wang, 2008) used the shared frailty model to analyze longitudinal measurements and time-to-event data, where multiple layers of models with shared underlining random variables are created for different data components. The general idea of shared frailty models is that different data components are assumed to be independent of each other conditioning on the shared random variables, and hence the correlation within the data structure is explained by the shared random variables. However, since these models assume that the sampling times are indepdent, none of them can be applied to longitudinal measurements of type (ii). Abundant attempts have been adopted study statistical model and inference of recurrent events and longitudinal measurements backward in time. For many diseases, including Alzheimer's Disease, the changes in biomarker performance before diagnosis of disease is widely recognized as an important index for predicting the disease (Hall et al., 2000; Wilson et al., 2007) . The conventional stochastic process models are always forward in time and not designed to study terminal behavior of processes. However, backward process models are more relevant for studying these terminal behavior (Chan and Wang, 2010; Chan and Wang, 2016) . In this paper, we will show that our model, though developed in forward time scale, has the consistent interpretation in the backward models under proper assumptions.
In Section 4, the method is generalized to the case where left truncation in failure time data is present. It handles the sampling designs when the study recruits only subjects who have experienced the initiating event but have not experienced the failure event. Under left truncation, it is well known that the time from initiating event to failure event tends to be longer than the failure time from the target population. We will use a data example from the Alzheimer's Disease to illustrate the proposed method.
The article is organized as follows. Section 2.1 introduces the joint model and discusses the interpretation of the joint model. An alternative model is presented in Section 2.2 and we show that the model has consistent interpretation in backward time perspective. Section 3 describes the estimation procedures and develops statistical properties of the proposed semiparametric estimators. The generalization to left truncation is discussed in Section 4.
In Section 5, we evaluate the performance of the estimating methods by simulation studies.
Real data from an Alzheimer's Disease study and an AIDS study are used as illustrating examples for data analysis in Section 6. Additional discussions are in included Section 7 to conclude the paper.
Survivors' Model

A Time-Adjusted Forward Model
Let T be the time from an initial event to the failure event which is in continuous time scale, Z a p × 1 vector of covariates, and R * (t) the counting process of the number of sampling times at or before time t. The longitudinal process Y (t) is measured repeatedly at time t where dR * (t) = 1. Suppose that the study is conducted in the time interval [0, τ ] and, potentially, the data information of {T, R * (t), Y (t)} is observed for 0 t τ . In reality, due to limitation in experimental design or other reasons, the data are subject to right censoring and only partially observed. Let C R be the censoring time for observing the sampling times and the longitudinal measurements {R * (·), Y (·)}. Let C T be the censoring time for the failure event. When framing the proposed model, we shall consider only the recurrent events and the longitudinal measurements occurring before the failure event, i.e. t T .
Consider the following assumption:
Under Assumptions (A1), we consider a time-adjusted forward model to characterize the joint relationship of {T, R * (·), Y (·)}: At any t 0, assume
where β T , β R and β Y is a p×1 vector of parameters, and T 0 , R * 0 (·) and Y 0 (·) are respectively the baseline failure time, the baseline recurrent event process and the baseline longitudinal process. The three components {T 0 , R Model (1), the notation R * e β T Z dt is used to indicate the jumps of the recurrent event process on the adjusted time scale, i.e.
Model (1) has an important feature as a survivors' model, in which only those who have not experienced the failure event are included when modeling the recurrent events and longitudinal measurements. The model assumes that the trajectories of a subject's recurrent event and longitudinal measurement processes in the survivors' population are elongated or shortened by the regression function identified from the accelerated failure time model (Kalbfleisch and Prentice, 1980 Note that Assumption (A1) specifies the independent censoring assumption. The condition (T t) in Model (1) has the practical interpretation that {R * (·), Y (·)} is required to exist only for the time before the failure event, and therefore allows Model (1) to capture the covariate effects on the survivors' population and avoids the arguable issue of longitudinal variables or recurrent events after the failure time. Additionally, the survivors' population changes when t varies, and this special characteristic is indicated by the condition (T t).
The conditioning event R * (exp(β T Z)dt) = 1 in the third layer of Model (1) Lin and Ying (2001) .
As mentioned in Section 1, Model (1) is applicable to the two types of longitudinal measurements (i) and (ii), where the rate of sampling process in the rescaled time index is changed by a multiplier exp(β T Z) compared to baseline. For the special case when the rate of sampling points is pre-planned and constant overtime, the rate of R * (t) is not influenced by covariates and we have β R = β T . In this case, the non-zero β R is the rescaling effect rather than the covariate effect. Note that the case β R = 0 implies that the recurrent event process is affected by the covariates only through rescaling the time to failure event, where the recurrent event process is stretched or compressed. Thus, a positive or negative β R reflects the additional inflation or deflation of the frequency of R * (·) explained by the covariates.
An Alternative Model and Its Backward Property
By rescaling time index, we construct an alternative model, termed as Model (2). This model is slightly stronger than Model (1), and possesses an attractive feature of having consistent interpretation in both the forward and backward models as will be explained later. Under the independent censoring assumption (A1), Model (2) assumes
Model (2) extends the joint model of failure time and recurrence events studied by Huang and Wang (2003) to a joint model with the additional longitudinal measurement Y (·). Note that by conditioning on T , the baseline failure time T 0 plays a role similar to a subjectivespecific random effect or frailty, and the model identifies the regression effect on Z. Huang and Wang (2003) indicated that their recurrent event model extends to
In our case, under Model (2), the longitudinal measurement satisfies
Thus, the regression model of Y (·) in Model (1) would be validated by Model (2), and a similar argument extends to the model for R * (·) to conclude that the validity of Model (2) implies Model (1). Essentially, Model (1) can be thought of as a marginal model of Model (2), since T is used as a part of conditional statistics in the latter but not in the former.
Interestingly, as a special property, Model (2) infection as an illustrating example, it is scientifically and clinically interesting to understand the pattern of the frequency and severity of opportunistic infections before death. Evidence suggests that HIV-infected patients experienced higher frequency of AIDS-defining events before death, where the frequencies could vary with gender, risk behaviors or geographic location (Chan et al., 1995) . Similar terminal behaviors are studied for Alzheimer's Disease (Wilson et al., 2007) , renal disease (Usvyat et al., 2013) and functional decline in the general population (Lunney et al., 2003) . To set notation, let the backward time index be denoted by t B which stands for the time counted retrospectively from the failure event. Define the backward process of the longitudinal measurement as
Under Assumptions (A1), by aligning failure events as time origins and counting time backward, it can be proved that Model (2) holds if and only if the following backward model
Model (3) The proof for equivalence between Models (2) and (3) is provided in the Web Appendix A.
Estimation
In this section we introduce and discuss the estimation procedures of Models (1) and (2).
be the censoring indicator of the failure event. Assume the observations
. . , n, are independent and identically distributed (i.i.d.). For most applications, the censoring time for recurrent events and longitudinal measurements is either the same as or less than the censoring time for the failure event.
We therefore assume P (C R C T ) = 1.
We construct three-layer estimation functions for β T , β R , β Y , separately but in a cer-tain ordering, for Model (1). As the first step, the weighted log-rank estimating equations (Tsiatis, 1990 ) is popular among other approaches (Buckley and James, 1979; Ritov, 1990) for estimating β T in the AFT model. We define the adjusted risk-set indicator of failure event by ξ T i (t; β T ) = I [XTi t exp(β T Z i )] and the adjusted counting process of failure event by
where W T (t; β T ) is a non-negative weight function. A zero-crossing of U T (β T ) = 0 exists, termed asβ T , as the estimator of β T which is strongly consistent and asymptotically normal under regular conditions (Ying, 1993) .
In the next step we use the approach of Huang and Wang (2003) to construct an estimator for β R . For given β T , define the adjusted risk-set indicator of recurrent event process by
and the adjusted counting process of recurrent event process as
and its zero-crossing is a consistent estimator of β R (Huang and Wang, 2003) . Replacing β T byβ T , we solve the equation U R (β R ;β T ) = 0 instead and denote the zero-crossing solution
In the third step of estimation, we estimate the parameters β Y via an estimation equation of (β Y ,β T ,β R ). The rate function of recurrent events process in survivors' population at baseline is E {dR * 0 (t) | T 0 t} = P (T 0 t) −1 dE {R * 0 (t)} , and the baseline cumulative recurrence rate function of survivors' population is Λ R 0 (t) = t 0
which is an unspecified function of t, and define
All the baseline information is structurally combined in A 0 (t), because one can prove that
Therefore, a mean-zero stochastic process for the ith subject can be expressed as
which leads to two estimation equations:
Based on (8), we develop an estimator for dA 0 (t) and A 0 (t), respectively, as
Replacing A 0 (t) byÂ 0 (t) in (9), we create an estimating function of β Y with given {β T , β R }:
Simple algebraic calculation yields
So, by similar arguments of Lin et al. (2000) , n −1/2 U Y (β Y ; β T , β R ) will converge weakly to a zero mean Gaussian process with continuous sample paths. A zero-root of U Y (β Y ; β T , β R ) = 0 will be a consistent estimator of β Y .
Replacing β T and β R byβ T andβ R respectively, we estimate β Y by the zero-root
invertible, there is a closed form of the solution aŝ
which substantially relaxes the burden of computation.
Under Model (2), the estimation procedures are essentially the same as those under Model
(1) because Model (1) is induced from Model (2): By re-defining
the regression parameters can be estimated by solving estimating equations (4), (5) and (11) (see the Web Appendix B). The estimation of the backward model, (3), can also be achieved via Model (1).
We develop asymptotic properties of the regression estimators with constant weight functions, which are shared by Models (1) and (2). Define
and the trivariate estimating function
Similar to Ying (1993) and Lin et al. (2000) , we introduce the following conditions:
(C1) β is restricted in a compact set.
(C3) The densities of T and dR * (t) and their first order differential functions are bounded.
(C4) The censoring time C T and C R have uniformly bounded densities, termed as g T and g R respectively, e.g. there is B c such that |g T (t)| < B c and |g R (t)| < B c for all t.
(C5) E| min{ln T − β T Z, C T , C R }| φ < ∞ for some φ > 0.
Theorem 3.1: Under conditions (C1-5), n −1/2 U (β) converges weakly to a multivariate normal random variable with mean zero and variance denoted as Σ, and U (β) is asymptotically linear in the sense that there exists a matrix A n such that for every sequence d n > 0 with d n → 0 in probability, we have
If the eigenvalues of A n are all bounded away from zero for all large enough n and A n → A where A is nonsingular, there exists a closed neighborhood N containing β as its interior point such thatβ is strongly consistent and n 1/2 (β − β) converges to N (0,
The proof of Theorem 3.1 is presented in the Web Appendix C. Of note, the matrix A involves the true distributions of recurrent events, longitudinal measurements and censoring with covariates, and is hard to estimate in practice. For data applications we will use the Bootstrap approaches to estimate the confidence intervals.
Extension to Left Truncation
In biomedical studies, left-truncated sampling is commonly adopted, where only those subjects who have experienced the initiating event but have not experienced the failure event are recruited and followed until the occurrence of failure event or censoring; see Wang, Brookmeyer, and Jewell (1993) , among others. The failure time of interest is still the time from initiating event to failure event in the target population, and this type of sampling results in left-truncated and right-censored failure time data along with accompanied recurrent events and longitudinal measurements. For example, in Alzheimer's Disease studies, the failure time T is age at onset of symptoms of Mild Cognitive Impairment (MCI), and the study recruited and followed only those subjects who were disease-free at baseline. The observed data sample then forms an example of left-truncated and right-censored data.
Our Model (1) and the subsequently developed inferential approach can be generalized to left-truncated and right-censored data under the conditional independent left truncation and right-censoring assumption, i.e. {T,
where L is the left trucation time, given covariates Z. Suppose the observations
To estimate Model (1) under the lefttruncated and right-censored sampling, we re-construct the risk set indicators and the counting processes (Andersen et al., 2012) . In particular, we define ξ
. Estimation procedures similar to those in Section 3 can be achieved using the following three-layer estimation functions:
Simulation Studies
We conducted simulation studies to assess the finite sample performance of the proposed methods. For each simulation study, we repeatedly generated 1, 000 simulated data sets. In each data set, the ith individual's sample is generated by the following procedure:
• Generate the covariate vector Z i .
• Generate the potential baseline failure time T 0i independently with Z i . Since T 0i > 0, we generate a random variable V i independent with Z i and define T 0i = exp(V i ). Thus, conditioning on T 0i is equivalent to conditioning on V i .
• Define the failure time as
• Conditioning on {V i , Z i }, generate the sampling time process R * i (·) on [0, τ ] as a nonhomogeneous Poisson process with intensity λ i (t;
where h(·, ·) is a prespecified positive function. Of note, this intensity function satisfies the requirement of Model (2) 
• Given V i and Z i , at each sampling time t, generate the longitudinal variable by
Here a(·), µ(·) and σ 2 (·) are prespecified functions.
• Generate censoring times {C T i , C Ri } which depend on the covariate Z i but do not depend on V i . Here, we set
In Table 1 all the specific distributions used to generate the simulated data are listed.
The simulation procedure follows Model (2) exactly and is determined by the prespecified The simulation results are summarized in Table 1 . Scenario 0 simulated the special case of type (i) longitudinal measurements with the constant samping rate overtime. Note that R * (·)
was not influenced by Z in this case and we let β R equal β T for the reason mentioned in the Section 2.1. The samping process considered in Scenario 1 followed a stationary Poisson process and was independent after conditioning on Z. In Scenarios 2-3, T were correlated with both R * (·) and Y (·). Scenario 1 and 2 involved a continuous and a discrete one-dimensional covariate separately. Scenario 3 mimicked a two-arm clinical trial with one covariate from Bernoulli distribution and another covariate from uniform distribution. We used the empirical bias, standard errors and 95% bootstrap confidence intervals for (β T , β R , β Y ) to evaluate the performance of the estimation method. The bootstrap procedure was based on 1, 000
replications, where subjuects were sampled with replacement and parameters {β T , β R , β Y } were estimated for each replication. As shown in Table 1 , the estimating method performed well in all the situations considered here. In particular, the 95% bootstrap confidence interval of β Y has empirical coverage probabilities ranging from 0.925 to 0.954 which accords with the asymptotic normality property.
Simulations studies on sensitivity analysis under the Scenario 2 illustrated that ignoring dependence of data with failture times could lead significantly biased results if the dependence existed (see the Web Appendix D).
[ Table 1 about here.]
Real Data Examples
BIOCARD Data Analysis
As an example of type (i) longitudinal measurements, we consider the application of our models on the data from the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) cohort study which aims at identifying biomarkers associated with the development of Alzheimer's Disease (AD) procession. The study was administrated by NIH from 1995 to 2005, and was re-established by a research group at Johns Hopkins School of Medicine after being stopped for four years. Subjects enrolled in the study were cognitively normal at baseline and data including cognitive performance testing scores were collected annually or per half year during the study.
The ε4 allele of the apolipoprotein E (ApoE) gene is the main genetic risk factor associated with AD dementia (Farrer et al., 1997) . Our main object here is to estimate the effect of the ApoE4 gene on the time onset of clinical symptoms and the cognitive performance testing score Logical Memory IIA -delayed. Here we only considered the data collected at the even follow-up years in 1995-2005. Totally, we had 236 subjects, consisting of 71 ApoE4 carriers and 165 ApoE4 non-carriers, and the overall censoring rate is 73.7%. Figure 1 shows the BIOCARD data of uncensored subjects in forward and backward time scales. We first analyzed the data as the right-censored case where the individual enrollment time was the time origin. Let T i be the time from entry to the onset of symptoms for mild cognitive impairment (MCI), R i (·) be the sampling process since entry and Y i (·) be the cognitive score, i = 1, . . . , 236. This longitudinal measurement is selected because it is found to be a highly predictive marker for onset of symptoms. Since subjects were enrolled at different baseline ages, the centered baseline age of each individual was considered as covariate. By defining the failure time T i as the age at onset of symptoms, the second set of data analysis is conducted by treating the observed data as being left-truncated and right-censored, where the truncation time L i is an individual's age at the time when she or he entered the study.
In this analysis ApoE4 status was the only covariate.
[ Figure 1 about here.]
The analysis results are reported in Table 2 . For the right-censored data setting, the ApoE4 gene type has a time rescaling effect identified by the AFT model. The positive ApoE4 gene type accelerates the progress of disease and, as a result, the time to onset of symptoms is shortened by the rate exp(−0.209) for subjects with the same baseline age. Furthermore, the score in the ApoE4 carriers population at time t exp(−0.209) averagely equals to that in the ApoE4 non-carriers population at time t with an additional increase by a coefficient with value 0.560. Of note, β Y represents the addition shift effect after being adjusted by the timerescaling effect, and therefore these two effects should be considered together to understand the covariate effect. Neither the time rescaling effect nor the additional shift effect of ApoE4 gene type showed significant effects according to the 95% bootstrap confidence intervals with 1, 000 bootstrap repetitions. In contrast, the increase of baseline age significantly accelerates the disease process and reduces the score as shown in Table 2 .
For the left-truncated and right-censored data setting, using a subject's age at onset of symptoms as the failure time, the positive ApoE4 gene type accelerates the progress to disease and shortens the age of onset of symptoms by rate exp(−0.044). Furthermore, the ApoE4 gene type influenced the rescaled recurrent event proess with an additional multiplier term exp(−0.035). As to the effect of ApoE4 on the score, it provides an additional shift effect by 0.831, but nonsignificantly.
[ and zalcitabine (ddC), for HIV-infected patients who had previously failed treatment with or were intolerant to zidovudine . In the trial, 230 patients were randomly sellected to receive ddI treatment and 237 to receive ddC, the event of death is the primary endpoint, and patients were followed until death or censoring. During the course of the trial 363 opportunistic infections were observed, of which 172 were in the ddI group and 191 in the ddc group. For each opportunistic infection, a severity score was provided by physicians as an indicator for the disease progression . The analysis in suggested that ddC may have provided a survival advantage over ddI.
We investigated the effect of treatment where the indicator, Z, was the only covariate in the model (coded as 0 for ddI and 1 for ddC). Let T , R * (·) and Y (·) respectively be the time to death, the opportunistic infection process and the severity score. The analysis results are summarized in Table 3 , which shows that the treatment ddC had a significant time rescaling effect and elongated the survival time by the rate exp(0.179). The infection rate of the ddC treatment group at time t exp(0.179) is equal to that of the ddI treatment group at time t with an additional multiplier exp(0.156), which is not significant. Moreover, the mean severity score of the ddC treatment group at time t exp(0.179) is equal to that of the ddI treatment group at time t with an additional increase 0.268 which is also not significant.
[ Table 3 about here.]
Discussion
In this paper we developed a joint model for longitudinal measurements, recurrent events, and failure events data where all of the three components of data are treated as outcomes.
Without requiring restrict assumptions on recurrent event processes, the proposed model is applicable to both types of longitudinal measurements, (i) and (ii). On the basis of the survivors' population, the model avoids the disputing assumption on the existence of recurrent events or longitudinal measurements after the failure event. As the model does not involve latent variables, computationally it is simpler and easier to adopt when comparing to the shared frailty model. Moreover, the proposed model and estimation inference can be generalized to analyze left-truncated and right-censored data.
The proposed model involves semiparametric structure in each of the three sub-models, for failure time, recurrent events and longitudinal measurements, and the baseline functions in the model are unspecified. Since the main interest of this article is to model and estimate covariates effects, we will only briefly describe the approaches for estimating the baseline functions in the Appendix and show the simulation studies in the Web Appendix E.
Our model possesses a specific feature that the forward time model is equivalent to the backward-in-time model for recurrent events and longitudinal measurements, where the two models share the same regression parameter values. Therefore, our model can be used to study the terminal behavior of biological processes, such as the performance of a biomarker measurement before the diagnosis of disease or the medicine cost distributions before death.
Of note, studying the terminal behavior of a longitudinal measurement process is challenging as the censoring cannot be handled using the standard approach (Chan and Wang, 2016 ). The proposed model possesses equivalence between forward and backward time scales, which is an attractive feature when modeling stochastic processes (such as recurrent events, longitudinal or functional measurements) in the presence of a terminal event. It has the obvious advantage that one can build a forward time model which is also valid in backward time scale.
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Appendix
The Inference of Baseline Functions
For Model (1) and (2), with estimated regression parameters, we can estimate A 0 (t) by (10), and estimate Λ R 0 (t) by a Breslow-type estimator (Breslow, 1972) 
For Model (1), α 0 (t) = E {Y 0 (t)|T 0 t, R * 0 (dt) = 1} can be estimated by Kernel Smoothing method (Ramlau-Hansen, 1983 )
where
) is a kernel function with bandwidth h,
K(x)dx = 1, and
xK(x)dx = 0. Using the empirical process theory (Van Der Vaart and Wellner, 1996; Kosorok, 2008) and Kernel Smoothing techniques (Ramlau-Hansen, 1983 ) one can show that each of the processes n 1/2 {Â 0 (t;β T )−A 0 (t)}, n 1/2 {Λ R 0 (t;β T )−Λ R 0 (t)} and (nh) 1/2 {α 0 (t;β T )− α 0 (t)} converges weakly to mean-zero Gaussian processes by weak convergence theory for functional parameters. Since these baseline functions are not the focus of our work, we skip details of the asymptotic proofs. The simulation studies are shown in the Web Appendix E. Note: Bias, the empirical bias; SE, the empirical standard error; CP , the empirical coverage probability of 95% bootstrap confidence interval; B(1, ), the Bernoulli distribution; N (µ, σ 2 ), the normal distribution; U [l 1 , l 2 ], the Uniform distribution;
Exp(λ), the Exponential distribution. 
